Propranolol Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 10 mg, 20 mg, 40 mg, 60 mg, 80 mg
Reference Brands: Inderal®(US & EU); Avlocardyl®(EU)
Category:
Antipsychotropic Drugs
Propranolol is a non-selective beta-adrenergic blocker that inhibits both β1 and β2 receptors, leading to decreased heart rate, myocardial contractility, and blood pressure. It also reduces sympathetic nervous system activity. Propranolol tablets are used to treat hypertension, angina, cardiac arrhythmias, post-myocardial infarction management, migraine prophylaxis, essential tremor, and anxiety-related symptoms.
Propranolol Tablets is available in Oral tablets
and strengths such as 10 mg, 20 mg, 40 mg, 60 mg, 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Propranolol Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Propranolol Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Propranolol tablets are FDA-approved in the United States for a wide range of indications including hypertension, angina pectoris, cardiac arrhythmias, myocardial infarction, migraine prophylaxis, and essential tremor. Regulatory requirements include GMP-compliant manufacturing, submission of bioequivalence data for generics, and adherence to labeling for cardiovascular safety and CNS effects. Propranolol is a non-selective beta-blocker, and all U.S. approvals must comply with pharmacovigilance and controlled substance exclusion. In the European Union, propranolol tablets are authorized under national marketing authorizations, with similar indications and requirements for Risk Management Plans (RMPs) and pharmacovigilance. For B2B sourcing and dossiers, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing